Drugs / Sabin Poliomyelitis Vaccine (Inactivated)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03169725 | May 2017 → Jan 2019 | poliomyelitis | LG Chem | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin Poliomyelitis Vaccine (Inactivated) | “'LBVC (Sabin Poliomyelitis Vaccine (Inactivated))' Compared With 'Imovax® Polio (Poliomyelitis Vaccine (Inactivated))' in Healthy Infants” NCT03169725 ↗ |
| Known as | LBVC | “'LBVC (Sabin Poliomyelitis Vaccine (Inactivated))' Compared With 'Imovax® Polio (Poliomyelitis Vaccine (Inactivated))' in Healthy Infants” NCT03169725 ↗ |
| Modality | Vaccine | “A new inactivated polio vaccine made from Sabin strains (sIPV) was developed as part of the global polio eradication initiative.” PMID 33351072 ↗ Aug 2022 |
| Route | Intramuscular | “Should be injected by intramuscular three injections in the anterolateral aspect of thigh at 6, 10 and 14 weeks of age.” NCT03169725 ↗ |